NICE, France--(BUSINESS WIRE)--Caranx Medical (‘Caranx’), a French medical device company specializing in the development of autonomous robot to democratize access to Transcatheter Aortic Valve ...

Valvular heart disease affects about 25 million people in China and 100 million worldwide every year. Nearly 50% suffer from conditions in aortic valve — the main outflow valve from the heart. Without ...

Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transcatheter aortic valve implantation (TAVI) has emerged as the primary treatment strategy for severe ...

While it’s possible to protect the coronary ostia, sometimes with a stent and sometimes with leaflet modification, it might be in patients’ best interest if the heart team goes with surgical aortic ...

COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter ...

Nearly one in four patients who undergo TAVI with a balloon-expandable valve develop new microbleeds visible on MRI in the days thereafter, according to results from the small, observational ...

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...

May 23, 2011 (Paris, France) — If a patient being considered for transcatheter aortic-valve implantation (TAVI) is found to have coronary disease, should that be treated as well? That's a question ...

In that high-risk group, in-hospital mortality was "just as good, if not better" with TAVI as with conventional aortic-valve surgery, said Dr Christian W Hamm (Kerckhoff Heart and Thorax Centre, Bad ...